HIV-1 pre-exposure prophylaxis
Infectious disease · 2017–2023
2decisions
2medicines
2carried consumer input
9individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| cabotegravir Pre-exposure prophylaxis (PrEP) for HIV-1 infection in persons in whom tenofovir disoproxil and emtricitabine (TD/FTC) is contraindicated, or persons who are… | Sep 2023 | Recommended with restriction | 6 individuals West Australian AIDS Council · Australian Federation · National Association · HIV Australia |
| tenofovir disoproxil fumarate / emtricitabine Pre-exposure prophylaxis (PrEP) against HIV-1 in adults at medium to high risk of infection. | Jul 2017 | Deferred | 3 individuals |
Who spoke
West Australian AIDS Council · Australian Federation · National Association · HIV Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.